# 3Mixtatin and MTA Vital Pulpotomy in Primary Molars

> **NCT06478940** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Cairo University** · enrollment: 50 (estimated)

## Conditions studied

- Pulp Disease, Dental
- Deciduous Teeth

## Interventions

- **DRUG:** 3 mixtatin pulpotomy
- **DRUG:** MTA pulpotomy

## Key facts

- **NCT ID:** NCT06478940
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06478940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06478940, "3Mixtatin and MTA Vital Pulpotomy in Primary Molars". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06478940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*